Five vaccines in development for HIV, tuberculosis, cancer, influenza, and coronaviruses could transform global health.
CAMBRIDGE, MA / ACCESS Newswire / April 6, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will ...
That raises the stakes for a second area of Moderna’s research. In a partnership with Merck, it’s been using its mRNA ...
Researchers at the University of Wisconsin School of Veterinary Medicine have identified a possible way to make ...
Christopher Locher, PhD, CEO, Versatope Therapeutics, Inc., tells his us about his version of a universal flu vaccine while ...
Researchers are advancing several norovirus vaccine candidates, such as oral tablet-based platforms, mRNA vaccines, and virus-like particle technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results